Supplement Scholar
Fatty Acid

Omega-3 (EPA/DHA)

Buy on Amazon ↗

Affiliate link: we may earn a commission at no extra cost to you. Disclosures

Omega-3 (EPA/DHA). Marine long-chain omega-3s — the most-studied anti-inflammatory and cardiovascular nutrient.

How it works. EPA/DHA replace arachidonic acid in cell membranes, shifting eicosanoid production from pro-inflammatory (PGE2) to resolution mediators (resolvins, protectins).

What the research supports. 4 graded claims. Strongest: Reduces triglycerides (strong).

How much to take. Typical dose: 2–3 g combined EPA+DHA. With largest fatty meal.

Side effects and interactions. 2 medication interactions listed. Serious: Atrial fibrillation risk at 4 g/day in some trials.

Stacking. Pairs well with Vitamin E, Vitamin D3. Avoid combining with High-dose vitamin E + other antioxidants.

Forms. 2 forms. Pick one to open its profile.

Key studies. 11 studies cited. The strongest are listed with links to PubMed.

Community. Experiences from people who have tried Omega-3 (EPA/DHA). Anecdotes are not medical advice.

Omega-3 (EPA/DHA). Marine long-chain omega-3s — the most-studied anti-inflammatory and cardiovascular nutrient.

Molecular structureC60H92O6 · 909.4 g/mol

What it is

Long-chain polyunsaturated fatty acids (EPA and DHA) found in fatty fish and algae. Incorporated into cell membranes and serve as precursors to anti-inflammatory eicosanoids.

Also called

Fish Oil

Food sources

SalmonMackerelSardinesAnchoviesAlgae (vegan source)

Goals

How it works

EPA/DHA replace arachidonic acid in cell membranes, shifting eicosanoid production from pro-inflammatory (PGE2) to resolution mediators (resolvins, protectins).

Pathways

  • Eicosanoid production (COX/LOX)
  • Specialized pro-resolving mediators (SPMs)
  • Membrane fluidity

Effects

  • ↓Triglycerides (~20–30%) decreases
  • ↓Systemic inflammation (hs-CRP) decreases
  • +Membrane health & cognition supports
  • ↓Resting heart rate decreases

What the research supports

Reduces triglyceridesstrong
Reduces major cardiovascular events at high-dose prescription EPAstrong
Reduces depression severity (especially EPA-dominant)moderate
Reduces joint pain in rheumatoid arthritismoderate

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Typical dose
2–3 g combined EPA+DHA
TimingWith largest fatty meal
With foodWith food containing fat — critical for absorption
Best formrTG (re-esterified triglyceride) form, third-party tested for oxidation
Upper limitFDA: 3 g/day from supplements (5 g total)
Shop Omega-3 (EPA/DHA) on Amazon ↗

As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.

Side effects & interactions

Common side effects

  • Fishy burps
  • Mild GI upset

Serious

  • Atrial fibrillation risk at 4 g/day in some trials

Medication interactions

Anticoagulants (warfarin, DOACs)moderate

May increase bleeding risk at high doses.

Anti-hypertensivesminor

Additive BP lowering.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Vitamin EProtects PUFAs from peroxidation.
  • Vitamin D3Synergistic for cardiovascular and immune health.

Avoid combining

  • High-dose vitamin E + other antioxidantsMay blunt some adaptive responses to training.

Key studies

11 studies cited in total.

PubMed: Omega-3 (EPA/DHA) — Reduces triglycerides ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces triglycerides". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Omega-3 (EPA/DHA) — Reduces major cardiovascular events at high-dose prescription EPA ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces major cardiovascular events at high-dose prescription EPA". Filter by RCT, meta-analysis, or year on the results page.

PubMed: Omega-3 (EPA/DHA) — Reduces depression severity ↗
Systematic review · PubMed (NLM) · 2026

Opens current human and preclinical literature matching Omega-3 (EPA/DHA) and "Reduces depression severity". Filter by RCT, meta-analysis, or year on the results page.

Discussion

Loading discussion…